Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pisarcik

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Gastroenterology & Hepatology|April 27, 2018
Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysisKamolyut Lapumnuaypol, Napatt Kanjanahattakij, David Pisarcik, et al.
The Indian Journal of Medical Research|June 19, 2021
Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysisKamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov WebsitePooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Gastroenterology & Hepatology|April 27, 2018
Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysisKamolyut Lapumnuaypol, Napatt Kanjanahattakij, David Pisarcik, et al.
The Indian Journal of Medical Research|June 19, 2021
Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysisKamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov WebsitePooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, et al.
Pageof 1